<DOC>
	<DOCNO>NCT02150044</DOCNO>
	<brief_summary>This non-significant risk ( NSR ) , prospective , multi-center , single arm clinical trial aim evaluate safety performance Acclarent Tympanostomy Tube Delivery System ( TTDS ) .</brief_summary>
	<brief_title>Acclarent Tympanostomy Tube Delivery System Treatment Patients Requiring Tympanostomy Tube Insertion</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<criteria>Diagnosed either chronic otitis medium effusion ( OME ) recurrent acute otitis medium ( AOM ) schedule undergo tympanostomy tube insertion History sensitivity reaction anesthesia choose procedure Markedly atrophic , mono bimeric , severely retract , atelectatic perforate tympanic membrane Otitis externa Active acute otitis medium Otitis medium pathology require Ttubes Stenosed ear canal Anatomy precludes sufficient visualization access tympanic membrane Anatomy necessitate tympanostomy tube placement posterior half tympanic membrane</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>